from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2851c/-

LFCtreatmentdescriptionclass of inhibitor

-0.672

Amikacinug/mL Amikacintranslation

-0.925

Cap5-10ug/mL Capreomycintranslation

-0.751

Rox10-50 ug/mL Roxithromycintranslation

-0.852

SM2-5 ug/mL Streptomycintranslation

-1.216

Tet5-10 ug/mL Tetracyclinetranslation

-0.459

Rif0.2-5ug/mL Rifampicintranscription

0.299

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.516

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.286

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.701

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.230

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.071

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.943

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.367

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.071

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.912

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.524

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.947

Nigericin50 uM Nigericinrespiration

0.011

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-1.007

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.489

menadione6-10 ug/mL Menadionerespiration

0.220

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.204

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.695

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.024

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.567

NRP_1Non-replicating persistence stage 1dosRassociated

0.392

Amp0.2mg/mL AmpicillincellWall

0.546

Cephalexin20-100 ug/mL CephalexincellWall

0.008

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.241

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.209

EMB10-20 ug/mL EthambutolcellWall

0.077

Eta12-40 ug/mL EthionamidecellWall

0.311

INH0.2-0.4 ug/mL IsoniazidcellWall

0.244

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.135

BZA0.12 mg/mL BenzamidearomaticAmides

0.097

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.098

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.049

H2O24 mM hydrogen peroxideDNAdamaging

-0.424

Levo10 ug/mL LevofloxacinDNAdamaging

-0.353

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.230

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.534

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.253

Antimycin12.5-50 ug/mL Antimycin A?

-0.726

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.167

PA_110-50 ug/mL Antitubercular compound PA-1?

0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.972

PA8240.2-2 ug/mL PA-824?

2.220

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.205

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.803

Verapamil50 uM Verapamil?

0.000

mercaptoethanol2 mM 2-Mercaptoethanol?

0.295

methoxatin10-20 ug/mL Methoxatin?